Bemis Company Reports Second Quarter Results and Announces Restructuring Program in Latin America – Business Wire (press release)

Restructuring

NEENAH, Wis.–(BUSINESS WIRE)–Bemis Company, Inc. (NYSE:BMS) today reported second quarter 2016 diluted earnings per share from continuing operations of $0.53. Excluding the effect of restructuring and acquisition-related costs detailed in the attached schedule, Reconciliation of Non-GAAP Earnings Per Share, adjusted diluted earnings per share from continuing operations would have been $0.67 in both 2016 and…

Deutsche Bank’s CEO just said something that should frighten the bank’s employees – Business Insider

Restructuring

Deutsche Banks profits nosedived from 800 million to just 20 million in the second quarter. The results were impacted by a tough environment for European banks, and a range of restructuring-related charges, as new CEO John Cryan looks to clean up the banks act. The bank took goodwill impairments of 285 million, restructuring and severance…

Business Restructuring International Oil Market Research Report Now Available at Research Corridor – The Republic of East Vancouver

Restructuring

Research Corridor has published a new research study titled Business Restructuring International Oil Market Growth, Share, Opportunities, Competitive Analysis and Forecast, 2015 2022. The Business Restructuring International Oil market report studies current as well as future aspects of the Business Restructuring International Oil Market based upon factors such as market dynamics, key ongoing trends and…

Metabolix (MBLX) to Implementing Strategic Restructuring Making Yield10 Bioscience its Core Business – StreetInsider.com

Restructuring

Get access to the best calls on Wall Street with StreetInsider.com’s Ratings Insider Elite. Get your Free Trial here. Metabolix, Inc. (NASDAQ: MBLX) announced today that it is implementing a strategic restructuring under which Yield10 Bioscience will become its core business with a focus on developing disruptive technologies for step-change improvements in crop yield to…

US investor buys J&J’s opiate API business and announces restructuring – In-PharmaTechnologist.com

Restructuring

SK Capital has rejigged the senior teams at opiate API maker Noramco and raw material supplier Tasmanian Alkaloids just weeks after buying the firms from Johnson & Johnson (J&J). The US private investment announced the changes today, explaining that Matthew Martin, previously the General Manager of both businesses, has been appointed as Noramco CEO. SK…